SCHEMBL7416586

SCHEMBL7416586

CCn1ncc2c(NCc3ccc(OC)cc3)c3ccccc3nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.52
APP P05067 2/20 0.51
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TP53 P04637 1/20 0.50
NCF1 P14598 1/20 0.49
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
ACP1 P24666 3/20 0.48
POLB P06746 2/20 0.48
RAD52 P43351 1/20 0.48
KMT2A Q03164 1/20 0.48
ABL1 P00519 1/20 0.48
SRC P12931 1/20 0.48
NR2F2 P24468 1/20 0.46
PDE9A O76083 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7423114 0.99 EGFR (0.51) EGFRAPPLMNASMN1; SMN2TP53
SCHEMBL7028354 0.90 KMT2A (0.60) APPLMNASMN1; SMN2MAPTPOLB
SCHEMBL7421877 0.89 TACR3 (0.51) EGFRLMNASMN1; SMN2TP53MAPT
SCHEMBL7424176 0.89 MEN1 (0.51) EGFRLMNASMN1; SMN2TP53MAPT
SCHEMBL7418464 0.89 APP (0.53) APPLMNASMN1; SMN2TP53MAPT
SCHEMBL7420540 0.87 POLB (0.50) POLBRAD52KMT2AABL1SRC
SCHEMBL7422887 0.86 ACHE (0.57) APPSMN1; SMN2MAPTTHRBPOLB
SCHEMBL7420650 0.86 PDE5A (0.50) LMNASMN1; SMN2MAPTPOLBRAD52
SCHEMBL7418635 0.85 POLB (0.51) MAPTPOLBRAD52KMT2AABL1
SCHEMBL8444030 0.81 ALDH1A1 (0.50) EGFRLMNASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
EP-0813410-A4 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP INC (US) 1998-08-19 EP disclosed
EP-0813410-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1997-12-29 EP disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed